Our identification of the TP53–PHKG2–PP1–NRF2 signaling cascade reveals a previously uncharacterized ferroptosis regulatory mechanism in HNSCC, highlighting redox imbalance as a critical vulnerability for therapeutic exploitation and paving the way for ferroptosis-based therapeutic interventions in redox-adapted tumors. This evidence concerns the gene PHKG2 and head and neck squamous cell carcinoma.